Metabolic Dysfunction-associated Steatotic Liver Disease
📧 Sign up to get email alerts when something new happens for Metabolic Dysfunction-associated Steatotic Liver Disease.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2026-06-25Clinical Trial Results: Early GLP-1 Receptor Agonist and SGLT2 Inhibitor Add-On Strategies in Adults With Obesity, Type 2 Diabetes, Cardiovascular-Kidney-Metabolic Syndrome Stage 2-3, and Metabolic Dysfunction-Associated Steatotic Liver Disease
Clinical trial results for early GLP-1 receptor agonist and SGLT2 inhibitor add-on strategies in adults with obesity, type 2 diabetes, cardi…
-
CLINICAL_TRIALS trial_result · 2026-04-23Clinical Trial Update: Identification and Characterization of At-risk MASLD in Turkish Adults
This completed clinical trial identifies and characterizes individuals at risk for Metabolic dysfunction-associated steatotic liver disease …
-
CLINICAL_TRIALS trial_result · 2026-04-22Clinical Trial Update: Integrated Ultrasound-Derived Fat Fraction and 2D/4D HeartAI for Cardiovascular Risk Management in Patients With MASLD
A clinical trial update describes using ultrasound-derived fat fraction and 2D/4D HeartAI to manage cardiovascular risk in MASLD patients, w…
-
CLINICAL_TRIALS trial_result · 2026-04-17Clinical Trial Update: Risk Factors and Prediction Model for Liver-Related Outcomes in Elderly Patients With Steatotic Liver Disease
The clinical trial update identifies risk factors and presents a prediction model for liver-related outcomes in elderly patients with steato…
-
CLINICAL_TRIALS trial_result · 2026-04-14Clinical Trial Update: A Phase 2a Study of ALN-PNP With and Without a GLP1R Agonist in Adult Patients With Homozygous PNPLA3-Related MASLD [Phase 2]
A Phase 2a trial evaluating ALN-PNP with and without a GLP-1 receptor agonist for homozygous PNPLA3-related MASLD is not yet recruiting.
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2026-04-13Clinical Trial Update: The Impact of Nutrition Education and Rice Bran Supplementation on Metabolic Dysfunction-associated Steatotic Liver Disease [NA]
A completed clinical trial evaluating the impact of nutrition education and rice bran supplementation on Metabolic dysfunction-associated st…
-
CLINICAL_TRIALS trial_result · 2026-04-08Clinical Trial Update: TUDCA in High-Risk Lactating Mothers Identified by Early Postpartum Milk Hydrophobicity Index [Phase 2]
Phase 2 trial investigating tauroursodeoxycholic acid (TUDCA) in high‑risk lactating mothers identified by an early postpartum milk hydropho…
-
CLINICAL_TRIALS trial_result · 2026-04-07Clinical Trial Update: The Impact Of SGLT2 -I on Metabolic Dysfunction -Associated Steatotic Liver Disease In Patients With Type 2 Diabetes Mellitus [Phase 3]
Phase 3 trial assessing the impact of an SGLT2 inhibitor on metabolic dysfunction-associated steatotic liver disease in adults with type 2 d…
-
CLINICAL_TRIALS trial_result · 2026-03-23Clinical Trial Update: Digital Pathology and AI for Liver Outcomes in MASLD
A completed clinical trial sponsored by PharmaNest evaluated digital pathology and AI for liver outcomes in MASLD. The study explored how di…
-
CLINICAL_TRIALS trial_result · 2026-03-23Clinical Trial Update: Developing Microbial Therapy for MASLD: From Mechanism to Clinical Validation [Phase 1]
Phase 1 clinical trial is evaluating a microbial therapy for Metabolic Dysfunction-Associated Steatotic Liver Disease (MASLD). Recruitment i…
-
CLINICAL_TRIALS trial_result · 2026-03-23Clinical Trial Update: Digital Pathology and AI for Liver Outcomes in MASLD (DPAILO-2)
The MASLD DPAILO-2 trial evaluating digital pathology and AI for liver outcomes has completed.
-
CLINICAL_TRIALS trial_result · 2026-03-19Clinical Trial Update: Structured Physical Activity Intervention in Patients With MASLD Receiving a Mediterranean Diet [NA]
A completed clinical trial evaluating a structured physical activity intervention in patients with MASLD who are receiving a Mediterranean d…
-
CLINICAL_TRIALS trial_result · 2026-02-25Clinical Trial Update: Study on Risk Factors and Prognosis of MASLD
A completed clinical trial investigating risk factors and prognosis for Metabolic Dysfunction-Associated Steatotic Liver Disease (MASLD) is …
-
CLINICAL_TRIALS trial_result · 2026-02-20Clinical Trial Update: Effects of Probiotics (P. Pentosaceus, L. Lactis or L. Helveticus) in NASH [Phase 1, Phase 2]
A completed phase 1/2 clinical trial sponsored by Chuncheon Sacred Heart Hospital evaluated the effects of probiotic strains Pediococcus pen…
-
CLINICAL_TRIALS trial_result · 2026-02-12Clinical Trial Update: Integrating Hepatological, Nutritional, and Psychological Support as a Multidisciplinary Management to Improve Long-term Clinical Outcomes in MASLD [NA]
A completed clinical trial evaluated a multidisciplinary management approach combining hepatology, nutrition, and psychology to improve long…
-
CLINICAL_TRIALS trial_result · 2026-02-05Clinical Trial Update: Adherence and Tolerability of Four Very Low-Calorie Ketogenic Diet Approaches in Adults With Obesity or Complicated Overweight
Completed clinical trial evaluating adherence and tolerability of four very low-calorie ketogenic diet approaches in adults with obesity or …
-
CLINICAL_TRIALS trial_result · 2026-01-12Clinical Trial Update: Screening and Intervention of MASLD in Children [NA]
This clinical trial update covers screening and intervention for MASLD (metabolic dysfunction-associated steatotic liver disease) in childre…
-
CLINICAL_TRIALS trial_result · 2026-01-12Clinical Trial Update: Dietary Strategies for MASLD (Metabolic Dysfunction-Associated Steatotic Liver Disease) [NA]
A completed clinical trial evaluating dietary strategies for MASLD (Metabolic dysfunction-associated steatotic liver disease) sponsored by t…
-
CLINICAL_TRIALS trial_result · 2025-12-30Clinical Trial Update: Nutritional Education Program for Metabolic Dysfunction-Associated Steatotic Liver Disease (MASLD) [NA]
The document reports an ongoing clinical trial at Taichung Veterans General Hospital evaluating a nutritional education program for metaboli…
-
CLINICAL_TRIALS trial_result · 2025-12-04Clinical Trial Update: Ultrasound-Based Estimation of Hepatic Steatosis in Pediatric MASLD [NA]
This clinical trial update notes the completion of a study evaluating ultrasound-based estimation of hepatic steatosis in pediatric MASLD.
-
CLINICAL_TRIALS trial_result · 2025-10-07Clinical Trial Update: Effects of Long-lasting Bicarbonate-Sulfate-Calcium-Magnesium Water Intake on Metabolic Dysfunction-Associated Steatotic Liver Disease (MASLD)-Related Outcome [NA]
Completed clinical trial assessing the effects of long-lasting bicarbonate-sulfate-calcium-magnesium water on outcomes related to metabolic …
-
CLINICAL_TRIALS trial_result · 2025-08-28Clinical Trial Update: Behavioral Lifestyle Intervention for Metabolic Dysfunction-associated Steatotic Liver Disease (MASLD) in Adults [NA]
This clinical trial update indicates that a behavioral lifestyle intervention for Metabolic dysfunction-associated steatotic liver disease (…
-
CLINICAL_TRIALS trial_result · 2025-08-01Clinical Trial Update: Lifestyle Habits and Metabolic Dysfunction-Associated Steatotic Liver Disease in Youth
A completed clinical trial by Harokopio University studied the relationship between lifestyle habits and Metabolic Dysfunction-Associated St…
-
CLINICAL_TRIALS trial_result · 2025-07-24Clinical Trial Update: Liver Fat as a Dietary Target of the Chinese Medical Nutrition Therapy (CMNT) Diet for Treating Type 2 Diabetes With Nonalcoholic Fatty Liver Disease (Version 3.0) [NA]
Clinical trial NCT07083336 is evaluating the Liver Fat-targeted CMNT diet as a dietary intervention for adults with Type 2 Diabetes Mellitus…
-
CLINICAL_TRIALS trial_result · 2025-07-17Clinical Trial Update: Clinical Efficacy of Pegylated Interferon Alpha-2b Combined With Nucleos(t)Ide Analogues in the Treatment of Chronic Hepatitis B Patients [Phase 4]
Phase 4 clinical trial update evaluating pegylated interferon alfa-2b in combination with nucleos(t)ide analogues for chronic hepatitis B, w…